Exo-AAV

N/A

Report date: 2025/03/20 15:54:18

Base Information

Drug NameExo-AAV
Drug Alias Nameengineered exosome AAV based gene therapy (Codiak Biosciences/Sarepta Therapeutics)
ClassificationBiologics > ExosomesCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuromuscular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodiak BioSciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCodiak BioSciences Inc
Inactive CompaniesN/A
Active IndicationsNeuromuscular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A